文献速递遗传性与小管间质肾病慢性肾脏病

VNtyper检测揭示ADTKD-MUC1表型异质性

Phenotypic Heterogeneity of ADTKD-MUC1 Diagnosed Using VNtyper, a Novel Genetic Technique.
PubMed 文献 · Am J Kidney Dis · 2025-01-22

本研究为横断面观察性研究,纳入2017至2023年转诊至Necker Enfants-Malades医院进行基因检测的4040例肾病患者,使用VNtyper计算流程检测MUC1 VNTR致病变异。共诊断40例ADTKD-MUC1患者(33例先证者,7例亲属),其中13例先证者临床未怀疑ADTKD,6例无肾病家族史,2例通过家系分离分析证实为新发突变。

要点

  • VNtyper可在常规短读长测序中可靠检测MUC1 VNTR致病变异。
  • 临床未怀疑ADTKD的患者中仍可检出ADTKD-MUC1,以不明原因CKD比例最高。
  • 部分ADTKD-MUC1患者无家族史,存在新发突变,需警惕不典型表现。

核心结论

  • VNtyper可在多种肾脏表型的大队列中诊断出临床未怀疑的ADTKD-MUC1。
  • 部分患者因合并另一基因变异而表现不典型,部分无肾病家族史且证实为新发突变。

研究设计与样本

  • 横断面观察性研究,纳入2017至2023年转诊至Necker Enfants-Malades医院进行基因检测的4040例患者。
  • 纳入因肾小球疾病、纤毛病、CAKUT、ADTKD或不明原因CKD转诊且既往未用SNaPshot微测序检测MUC1的患者。

主要发现

  • VNtyper共检出40例MUC1变异患者,包括33例新先证者和7例亲属。
  • 33例先证者中20例临床怀疑ADTKD,另13例临床未考虑ADTKD。
  • 临床未考虑ADTKD者中检出率:肾小球疾病0.05%(1/1895),纤毛病1.2%(4/329),CAKUT 0.09%(1/1099),不明原因CKD 2.5%(7/285)。
  • 6例无肾病家族史,家系分离分析证实2例为新发突变。

关键数值与推荐

  • ADTKD-MUC1诊断依据VNtyper检测MUC1 VNTR致病变异。
  • 临床未怀疑ADTKD的患者中,不明原因CKD的检出率为2.5%(7/285)。

临床怎么用

  • 对不明原因CKD、纤毛病等患者可考虑VNtyper检测MUC1 VNTR变异以发现不典型ADTKD-MUC1。
  • ADTKD-MUC1患者可无家族史,新发突变需通过家系分离分析确认。

局限性

  • 观察性研究,转诊人群存在选择偏倚,可能不代表一般肾脏病人群的患病率或表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Molecular diagnosis of autosomal dominant tubulointerstitial kidney disease (ADTKD) due to variants in the MUC1 gene has long been challenging because variants lie in a large variable number of tandem repeat (VNTR) region, making identification impossible using standard short-read techniques. Previously, we addressed this diagnostic limitation by developing a computational pipeline named VNtyper for easier reliable detection of MUC1 VNTR pathogenic variants from short-read sequences. This led to unexpected diagnoses of ADTKD-MUC1 among patients with kidney disease referred for genetic testing, which we report here. STUDY DESIGN: Cross-sectional observational study. SETTING & PARTICIPANTS: 4,040 patients referred to Necker Enfants-Malades Hospital from 2017 to 2023 for genetic testing for (1) glomerular disease, (2) ciliopathy, (3) congenital anomalies of the kidneys and urinary tracts (CAKUT), (4) ADTKD, or (5) chronic kidney disease (CKD) of unknown origin, in whom MUC1 had not been previously tested by SNaPshot minisequencing. EXPOSURE: Clinical suspicion of ADTKD. OUTCOME: ADTKD-MUC1 diagnosed using VNtyper. ANALYTICAL APPROACH: Data were collected from patients in whom ADTKD-MUC1 was newly diagnosed and patients in whom ADTKD was clinically suspected were compared with those in whom ADTKD was not. RESULTS: We identified 40 patients with MUC1 variants by VNtyper, including 33 new index patients and 7 relatives. Of the 33 index cases, 20 had been suspected of having ADTKD based on clinical features, and in the other 13 ADTKD had not been considered. In patients in whom ADTKD had not been considered clinically, the detection rate was 0.05% (1 of 1,895) among patients with glomerular disease, 1.2% (4 of 329) among patients with ciliopathy, 0.09% (1 of 1,099) among patients with CAKUT and 2.5% (7 of 285) among patients with CKD of unknown origin. In 6 patients there was no family history of kidney disease, and we confirmed de novo presentation in 2 patients by segregation studies. LIMITATIONS: Observational study and selected referral population (may not represent the prevalence or phenotypes in the general kidney disease population). CONCLUSIONS: With VNtyper, we were able to diagnose new cases of ADTKD-MUC1 in a large cohort of patients with various phenotypes. Some patients had atypical phenotypes due to a variant in another gene, and some had no family history of kidney disease, suggesting de novo disease, which was confirmed in 2 patients. PLAIN-LANGUAGE SUMMARY: Molecular diagnosis of autosomal dominant tubulointerstitial kidney disease due to variants in the MUC1 gene (ADTKD-MUC1) has long been challenging. Recently, we developed a computational pipeline named VNtyper to allow easier, reliable detection of MUC1 variants. When applied to a large heterogenous cohort of patients, it allowed us to diagnose ADTKD in patients in whom it had not been suspected. In some cases, this was due to 2 concomitant genetic diagnoses, which affected the phenotype. In others, there was no family history of kidney disease suggestive of an autosomal dominant disorder, and we were able to confirm de novo ADTKD-MUC1 in 2 patients.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Kachmar J, Saei H, Morinière V, et al. Phenotypic Heterogeneity of ADTKD-MUC1 Diagnosed Using VNtyper, a Novel Genetic Technique. Am J Kidney Dis. 2025. PMID: 39848530. doi:10.1053/j.ajkd.2024.11.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。